Moolec Science (MLEC) Cost of Revenue (2022 - 2024)
Moolec Science's (MLEC) quarterly Cost of Revenue came in at $3.3 million in Q4 2024, up 16453.56% year-on-year from N/an in Q1 2024, and up 115.1% quarter-over-quarter from $1.5 million in Q3 2024.
Moolec Science (MLEC) Cost of Revenue (2022 - 2024) Analysis & Trends
Moolec Science has disclosed Cost of Revenue across 3 years of filings, most recently posting $3.3 million for Q4 2024.
- Cost of Revenue for Q4 2024 came in at $3.3 million, up 16453.56% year-over-year; the trailing twelve-month figure through Dec 2024 was $286.2 million (up 20.77% YoY), and the FY2024 annual result was $279.4 million, up 18.65% from the prior year.
- Cost of Revenue came in at $3.3 million for Q4 2024 at Moolec Science, up from $1.5 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $279.4 million in Q2 2024 to a low of $208.37 in Q2 2022.
- The 3-year median for Cost of Revenue is $770057.5 (2022), against an average of $43.6 million.
- Peak annual rise in Cost of Revenue reached 113002024.17% in 2023, while the deepest fall reached 2.11% in 2023.
- Moolec Science's Cost of Revenue stood at $20473.0 in 2022, then retreated by 2.11% to $20040.0 in 2023, then soared by 16453.56% to $3.3 million in 2024.
- The last three Cost of Revenue figures came in at $3.3 million (Q4 2024), $1.5 million (Q3 2024), and $279.4 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 64.20 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 48,670.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 392.80 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 2.05 Mn |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 3.32 Mn |
| Dec 31, 2024 | 3.32 Mn |
| Sep 30, 2024 | 1.54 Mn |
| Sep 30, 2024 | 1.54 Mn |
| Jun 30, 2024 | 279.37 Mn |
| Jun 30, 2024 | 279.37 Mn |
| Mar 31, 2024 | 2.02 Mn |
| Mar 31, 2024 | 2.02 Mn |
| Dec 31, 2023 | 20,040.00 |
| Dec 31, 2023 | 20,040.00 |
| Sep 30, 2023 | 1.52 Mn |
| Sep 30, 2023 | 1.52 Mn |
| Jun 30, 2023 | 235.46 Mn |
| Jun 30, 2023 | 235.46 Mn |
| Mar 31, 2023 | 14,364.00 |
| Mar 31, 2023 | 14,364.00 |
| Dec 31, 2022 | 20,473.00 |
| Dec 31, 2022 | 20,473.00 |
| Sep 30, 2022 | 19,318.00 |
| Sep 30, 2022 | 19,318.00 |